Healthcare 21 Group (HC21) will be at Arab Health 2024 to showcase their specialist support services designed to help international MedTech manufacturers navigate the UK market with confidence.
Marking a pivotal point in a nine-year journey of innovation, OTSAW, a leader in Singapore’s robotics landscape, introduces Camello+, an autonomous mobile robot (AMR) poised to revolutionize various industries, including healthcare.
Arab Health will this year welcome over 40 country pavilions, including Serbia and Hong Kong, who will make their debut at the 2024 edition of the event A total of 73 countries will be represented by exhibitors as Arab Health takes over the Dubai World Trade Centre, with a total of 25 halls occupied More […]
SyntheticMR announced that their next-generation imaging solution with isotropic 3D resolution, SyMRI 3D, has obtained approval in the EU and is now CE-Marked. With preparations in place, SyntheticMR eagerly anticipates the commercial launch of SyMRI 3D at the start of 2024.
Phase IIa clinical trial evaluated Aurase Wound Gel in patients with venous leg ulcers Former Smith+Nephew CMO, Andy Weymann joins as Chairman to support progression of further Phase II clinical trials
Ergéa UK, vendor-neutral provider of Managed Equipment Services (MES), have announced the release of a comprehensive white paper that explores the evolution of MES and its role in helping to drive transformational change within healthcare organisations.
SyntheticMR announced expansion of their partnership with Philips to include SyMRI 3D.
The next-generation, Modus X, offering advanced 4K 3D optics and fluorescence modalities to enhance surgical visualization in neurosurgery, ENT, plastics, and spine makes it debut in Europe at Azienda Ospedaliera Universitaria Federico II in Naples, Italy.
After birth, the human heart loses its regenerative capacity almost completely. Damage to the heart muscle, e.g. due to a heart attack, therefore usually leads to a permanent loss of function in adults. However, scientists from the Max Planck Institute for Heart and Lung Research have now shown for the first time in mice that […]
Canadian life sciences company Ondine Biomedical has presented new research showing that their Steriwave photodisinfection device reduced antibiotic-resistant bacteria by more than 99.9%. The in vitro study, presented at the IP2023 annual conference in Liverpool in October, shows that photodisinfection can play an important role in strategies for combatting antimicrobial resistance.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
